{"entity":{"type":"insider","cik":"0001827198","url":"/insider/0001827198","json_url":"/insider/0001827198.json","name":"Laponis Adam","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":32,"n_filings":31,"first":"2021-07-01","last":"2026-08-25","span_basis":"filed_date"},"name_variants":[{"name":"Laponis Adam","source":"filing","n_filings":31,"first_seen":"2021-07-01","last_seen":"2026-08-25"}],"transactions":[{"id":9301135,"accession":"0001214659-26-010829","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001214659-26-010829","line_url":"/filing/0001214659-26-010829#line-1","is_derivative":false,"issuer_cik":"0001581280","issuer_name":"Twist Bioscience Corp","issuer_ticker":"TWST","issuer_name_source":null,"issuer_url":"/issuer/0001581280","owner_cik":"0001827198","owner_name":"Laponis Adam","owner_display_name":"Laponis Adam","owner_url":"/insider/0001827198","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1965.0,"shares_display":"1,965","price_per_share":139.066,"price_display":"139.07","price_state":"stated","total_value":273264.69,"total_display":"273,264.69","total_whole":"273,265","shares_owned_after":108633.0,"shares_owned_after_display":"108,633","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-21","filed_date":"2026-08-25","scope":"insider"},{"id":5752071,"accession":"0001214659-26-008480","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001214659-26-008480","line_url":"/filing/0001214659-26-008480#line-1","is_derivative":false,"issuer_cik":"0001581280","issuer_name":"Twist Bioscience Corp","issuer_ticker":"TWST","issuer_name_source":null,"issuer_url":"/issuer/0001581280","owner_cik":"0001827198","owner_name":"Laponis Adam","owner_display_name":"Laponis Adam","owner_url":"/insider/0001827198","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2399.0,"shares_display":"2,399","price_per_share":94.334,"price_display":"94.33","price_state":"stated","total_value":226307.266,"total_display":"226,307.27","total_whole":"226,307","shares_owned_after":110276.0,"shares_owned_after_display":"110,276","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-07-09","filed_date":"2026-07-13","scope":"insider"},{"id":6074094,"accession":"0001214659-26-007029","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001214659-26-007029","line_url":"/filing/0001214659-26-007029#line-1","is_derivative":false,"issuer_cik":"0001581280","issuer_name":"Twist Bioscience Corp","issuer_ticker":"TWST","issuer_name_source":null,"issuer_url":"/issuer/0001581280","owner_cik":"0001827198","owner_name":"Laponis Adam","owner_display_name":"Laponis Adam","owner_url":"/insider/0001827198","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":70.0,"price_display":"70.00","price_state":"stated","total_value":280000.0,"total_display":"280,000.00","total_whole":"280,000","shares_owned_after":112675.0,"shares_owned_after_display":"112,675","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-29","filed_date":"2026-06-02","scope":"insider"},{"id":6074089,"accession":"0001214659-26-006712","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001214659-26-006712","line_url":"/filing/0001214659-26-006712#line-1","is_derivative":false,"issuer_cik":"0001581280","issuer_name":"Twist Bioscience Corp","issuer_ticker":"TWST","issuer_name_source":null,"issuer_url":"/issuer/0001581280","owner_cik":"0001827198","owner_name":"Laponis Adam","owner_display_name":"Laponis Adam","owner_url":"/insider/0001827198","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2019.0,"shares_display":"2,019","price_per_share":53.257,"price_display":"53.26","price_state":"stated","total_value":107525.883,"total_display":"107,525.88","total_whole":"107,526","shares_owned_after":116675.0,"shares_owned_after_display":"116,675","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-21","filed_date":"2026-05-26","scope":"insider"},{"id":6203402,"accession":"0001214659-26-004893","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001214659-26-004893","line_url":"/filing/0001214659-26-004893#line-1","is_derivative":false,"issuer_cik":"0001581280","issuer_name":"Twist Bioscience Corp","issuer_ticker":"TWST","issuer_name_source":null,"issuer_url":"/issuer/0001581280","owner_cik":"0001827198","owner_name":"Laponis Adam","owner_display_name":"Laponis Adam","owner_url":"/insider/0001827198","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":60.0,"price_display":"60.00","price_state":"stated","total_value":240000.0,"total_display":"240,000.00","total_whole":"240,000","shares_owned_after":118694.0,"shares_owned_after_display":"118,694","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-04-17","filed_date":"2026-04-21","scope":"insider"},{"id":5984626,"accession":"0001214659-26-004735","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001214659-26-004735","line_url":"/filing/0001214659-26-004735#line-1","is_derivative":false,"issuer_cik":"0001581280","issuer_name":"Twist Bioscience Corp","issuer_ticker":"TWST","issuer_name_source":null,"issuer_url":"/issuer/0001581280","owner_cik":"0001827198","owner_name":"Laponis Adam","owner_display_name":"Laponis Adam","owner_url":"/insider/0001827198","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":55.0,"price_display":"55.00","price_state":"stated","total_value":165000.0,"total_display":"165,000.00","total_whole":"165,000","shares_owned_after":122694.0,"shares_owned_after_display":"122,694","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-04-14","filed_date":"2026-04-16","scope":"insider"},{"id":5860483,"accession":"0001214659-26-004601","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001214659-26-004601","line_url":"/filing/0001214659-26-004601#line-1","is_derivative":false,"issuer_cik":"0001581280","issuer_name":"Twist Bioscience Corp","issuer_ticker":"TWST","issuer_name_source":null,"issuer_url":"/issuer/0001581280","owner_cik":"0001827198","owner_name":"Laponis Adam","owner_display_name":"Laponis Adam","owner_url":"/insider/0001827198","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2597.0,"shares_display":"2,597","price_per_share":49.889,"price_display":"49.89","price_state":"stated","total_value":129561.733,"total_display":"129,561.73","total_whole":"129,562","shares_owned_after":125694.0,"shares_owned_after_display":"125,694","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-04-09","filed_date":"2026-04-13","scope":"insider"},{"id":5752031,"accession":"0001214659-26-002442","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001214659-26-002442","line_url":"/filing/0001214659-26-002442#line-1","is_derivative":false,"issuer_cik":"0001581280","issuer_name":"Twist Bioscience Corp","issuer_ticker":"TWST","issuer_name_source":null,"issuer_url":"/issuer/0001581280","owner_cik":"0001827198","owner_name":"Laponis Adam","owner_display_name":"Laponis Adam","owner_url":"/insider/0001827198","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2085.0,"shares_display":"2,085","price_per_share":46.7098,"price_display":"46.71","price_state":"stated","total_value":97389.933,"total_display":"97,389.93","total_whole":"97,390","shares_owned_after":128291.0,"shares_owned_after_display":"128,291","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-23","filed_date":"2026-02-25","scope":"insider"},{"id":6089881,"accession":"0001214659-26-001737","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001214659-26-001737","line_url":"/filing/0001214659-26-001737#line-1","is_derivative":false,"issuer_cik":"0001581280","issuer_name":"Twist Bioscience Corp","issuer_ticker":"TWST","issuer_name_source":null,"issuer_url":"/issuer/0001581280","owner_cik":"0001827198","owner_name":"Laponis Adam","owner_display_name":"Laponis Adam","owner_url":"/insider/0001827198","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7000.0,"shares_display":"7,000","price_per_share":50.0,"price_display":"50.00","price_state":"stated","total_value":350000.0,"total_display":"350,000.00","total_whole":"350,000","shares_owned_after":130031.0,"shares_owned_after_display":"130,031","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-12","filed_date":"2026-02-13","scope":"insider"},{"id":5850982,"accession":"0001214659-26-000509","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001214659-26-000509","line_url":"/filing/0001214659-26-000509#line-1","is_derivative":false,"issuer_cik":"0001581280","issuer_name":"Twist Bioscience Corp","issuer_ticker":"TWST","issuer_name_source":null,"issuer_url":"/issuer/0001581280","owner_cik":"0001827198","owner_name":"Laponis Adam","owner_display_name":"Laponis Adam","owner_url":"/insider/0001827198","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":40.0,"price_display":"40.00","price_state":"stated","total_value":120000.0,"total_display":"120,000.00","total_whole":"120,000","shares_owned_after":137031.0,"shares_owned_after_display":"137,031","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-13","filed_date":"2026-01-15","scope":"insider"},{"id":6074038,"accession":"0001214659-26-000423","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001214659-26-000423","line_url":"/filing/0001214659-26-000423#line-1","is_derivative":false,"issuer_cik":"0001581280","issuer_name":"Twist Bioscience Corp","issuer_ticker":"TWST","issuer_name_source":null,"issuer_url":"/issuer/0001581280","owner_cik":"0001827198","owner_name":"Laponis Adam","owner_display_name":"Laponis Adam","owner_url":"/insider/0001827198","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2738.0,"shares_display":"2,738","price_per_share":35.261,"price_display":"35.26","price_state":"stated","total_value":96544.618,"total_display":"96,544.62","total_whole":"96,545","shares_owned_after":140031.0,"shares_owned_after_display":"140,031","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-09","filed_date":"2026-01-13","scope":"insider"},{"id":4094821,"accession":"0001214659-25-017219","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001214659-25-017219","line_url":"/filing/0001214659-25-017219#line-1","is_derivative":false,"issuer_cik":"0001581280","issuer_name":"Twist Bioscience Corp","issuer_ticker":"TWST","issuer_name_source":null,"issuer_url":"/issuer/0001581280","owner_cik":"0001827198","owner_name":"Laponis Adam","owner_display_name":"Laponis Adam","owner_url":"/insider/0001827198","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":887.0,"shares_display":"887","price_per_share":26.5035,"price_display":"26.50","price_state":"stated","total_value":23508.6045,"total_display":"23,508.60","total_whole":"23,509","shares_owned_after":142769.0,"shares_owned_after_display":"142,769","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-21","filed_date":"2025-11-25","scope":"insider"},{"id":4373971,"accession":"0001214659-25-015763","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001214659-25-015763","line_url":"/filing/0001214659-25-015763#line-1","is_derivative":false,"issuer_cik":"0001581280","issuer_name":"Twist Bioscience Corp","issuer_ticker":"TWST","issuer_name_source":null,"issuer_url":"/issuer/0001581280","owner_cik":"0001827198","owner_name":"Laponis Adam","owner_display_name":"Laponis Adam","owner_url":"/insider/0001827198","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5517.0,"shares_display":"5,517","price_per_share":31.4443,"price_display":"31.44","price_state":"stated","total_value":173478.2031,"total_display":"173,478.20","total_whole":"173,478","shares_owned_after":111008.0,"shares_owned_after_display":"111,008","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-30","filed_date":"2025-11-03","scope":"insider"},{"id":4172676,"accession":"0001214659-25-014856","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001214659-25-014856","line_url":"/filing/0001214659-25-014856#line-2","is_derivative":false,"issuer_cik":"0001581280","issuer_name":"Twist Bioscience Corp","issuer_ticker":"TWST","issuer_name_source":null,"issuer_url":"/issuer/0001581280","owner_cik":"0001827198","owner_name":"Laponis Adam","owner_display_name":"Laponis Adam","owner_url":"/insider/0001827198","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2517.0,"shares_display":"2,517","price_per_share":32.922,"price_display":"32.92","price_state":"stated","total_value":82864.674,"total_display":"82,864.67","total_whole":"82,865","shares_owned_after":91525.0,"shares_owned_after_display":"91,525","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-09","filed_date":"2025-10-10","scope":"insider"},{"id":4172671,"accession":"0001214659-25-014856","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001214659-25-014856","line_url":"/filing/0001214659-25-014856#line-1","is_derivative":false,"issuer_cik":"0001581280","issuer_name":"Twist Bioscience Corp","issuer_ticker":"TWST","issuer_name_source":null,"issuer_url":"/issuer/0001581280","owner_cik":"0001827198","owner_name":"Laponis Adam","owner_display_name":"Laponis Adam","owner_url":"/insider/0001827198","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":31.15,"price_display":"31.15","price_state":"stated","total_value":93450.0,"total_display":"93,450.00","total_whole":"93,450","shares_owned_after":94042.0,"shares_owned_after_display":"94,042","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-08","filed_date":"2025-10-10","scope":"insider"},{"id":4172667,"accession":"0001214659-25-014777","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001214659-25-014777","line_url":"/filing/0001214659-25-014777#line-1","is_derivative":false,"issuer_cik":"0001581280","issuer_name":"Twist Bioscience Corp","issuer_ticker":"TWST","issuer_name_source":null,"issuer_url":"/issuer/0001581280","owner_cik":"0001827198","owner_name":"Laponis Adam","owner_display_name":"Laponis Adam","owner_url":"/insider/0001827198","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5875.0,"shares_display":"5,875","price_per_share":32.187,"price_display":"32.19","price_state":"stated","total_value":189098.625,"total_display":"189,098.62","total_whole":"189,099","shares_owned_after":97042.0,"shares_owned_after_display":"97,042","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-06","filed_date":"2025-10-08","scope":"insider"},{"id":5184700,"accession":"0001214659-25-012706","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001214659-25-012706","line_url":"/filing/0001214659-25-012706#line-1","is_derivative":false,"issuer_cik":"0001581280","issuer_name":"Twist Bioscience Corp","issuer_ticker":"TWST","issuer_name_source":null,"issuer_url":"/issuer/0001581280","owner_cik":"0001827198","owner_name":"Laponis Adam","owner_display_name":"Laponis Adam","owner_url":"/insider/0001827198","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":918.0,"shares_display":"918","price_per_share":25.964,"price_display":"25.96","price_state":"stated","total_value":23834.952,"total_display":"23,834.95","total_whole":"23,835","shares_owned_after":102917.0,"shares_owned_after_display":"102,917","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-21","filed_date":"2025-08-25","scope":"insider"},{"id":4533549,"accession":"0001214659-25-010310","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001214659-25-010310","line_url":"/filing/0001214659-25-010310#line-1","is_derivative":false,"issuer_cik":"0001581280","issuer_name":"Twist Bioscience Corp","issuer_ticker":"TWST","issuer_name_source":null,"issuer_url":"/issuer/0001581280","owner_cik":"0001827198","owner_name":"Laponis Adam","owner_display_name":"Laponis Adam","owner_url":"/insider/0001827198","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2449.0,"shares_display":"2,449","price_per_share":38.146,"price_display":"38.15","price_state":"stated","total_value":93419.554,"total_display":"93,419.55","total_whole":"93,420","shares_owned_after":103569.0,"shares_owned_after_display":"103,569","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-07-09","filed_date":"2025-07-11","scope":"insider"},{"id":4992446,"accession":"0001214659-25-008296","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001214659-25-008296","line_url":"/filing/0001214659-25-008296#line-1","is_derivative":false,"issuer_cik":"0001581280","issuer_name":"Twist Bioscience Corp","issuer_ticker":"TWST","issuer_name_source":null,"issuer_url":"/issuer/0001581280","owner_cik":"0001827198","owner_name":"Laponis Adam","owner_display_name":"Laponis Adam","owner_url":"/insider/0001827198","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":936.0,"shares_display":"936","price_per_share":29.747,"price_display":"29.75","price_state":"stated","total_value":27843.192,"total_display":"27,843.19","total_whole":"27,843","shares_owned_after":106018.0,"shares_owned_after_display":"106,018","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-05-21","filed_date":"2025-05-23","scope":"insider"},{"id":4273015,"accession":"0001214659-25-005780","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001214659-25-005780","line_url":"/filing/0001214659-25-005780#line-1","is_derivative":false,"issuer_cik":"0001581280","issuer_name":"Twist Bioscience Corp","issuer_ticker":"TWST","issuer_name_source":null,"issuer_url":"/issuer/0001581280","owner_cik":"0001827198","owner_name":"Laponis Adam","owner_display_name":"Laponis Adam","owner_url":"/insider/0001827198","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2542.0,"shares_display":"2,542","price_per_share":34.9674,"price_display":"34.97","price_state":"stated","total_value":88887.1308,"total_display":"88,887.13","total_whole":"88,887","shares_owned_after":106954.0,"shares_owned_after_display":"106,954","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-04-09","filed_date":"2025-04-11","scope":"insider"},{"id":4429097,"accession":"0001214659-25-003435","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001214659-25-003435","line_url":"/filing/0001214659-25-003435#line-1","is_derivative":false,"issuer_cik":"0001581280","issuer_name":"Twist Bioscience Corp","issuer_ticker":"TWST","issuer_name_source":null,"issuer_url":"/issuer/0001581280","owner_cik":"0001827198","owner_name":"Laponis Adam","owner_display_name":"Laponis Adam","owner_url":"/insider/0001827198","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":918.0,"shares_display":"918","price_per_share":44.177,"price_display":"44.18","price_state":"stated","total_value":40554.486,"total_display":"40,554.49","total_whole":"40,554","shares_owned_after":109496.0,"shares_owned_after_display":"109,496","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-21","filed_date":"2025-02-25","scope":"insider"},{"id":4942568,"accession":"0001214659-25-000554","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001214659-25-000554","line_url":"/filing/0001214659-25-000554#line-1","is_derivative":false,"issuer_cik":"0001581280","issuer_name":"Twist Bioscience Corp","issuer_ticker":"TWST","issuer_name_source":null,"issuer_url":"/issuer/0001581280","owner_cik":"0001827198","owner_name":"Laponis Adam","owner_display_name":"Laponis Adam","owner_url":"/insider/0001827198","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5886.0,"shares_display":"5,886","price_per_share":43.263,"price_display":"43.26","price_state":"stated","total_value":254646.018,"total_display":"254,646.02","total_whole":"254,646","shares_owned_after":110096.0,"shares_owned_after_display":"110,096","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-10","filed_date":"2025-01-14","scope":"insider"},{"id":9273632,"accession":"0001214659-24-019254","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001214659-24-019254","line_url":"/filing/0001214659-24-019254#line-1","is_derivative":false,"issuer_cik":"0001581280","issuer_name":"Twist Bioscience Corp","issuer_ticker":"TWST","issuer_name_source":null,"issuer_url":"/issuer/0001581280","owner_cik":"0001827198","owner_name":"Laponis Adam","owner_display_name":"Laponis Adam","owner_url":"/insider/0001827198","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4160.0,"shares_display":"4,160","price_per_share":44.605,"price_display":"44.60","price_state":"stated","total_value":185556.8,"total_display":"185,556.80","total_whole":"185,557","shares_owned_after":89237.0,"shares_owned_after_display":"89,237","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-06","filed_date":"2024-11-15","scope":"insider"},{"id":2038080,"accession":"0001214659-24-018614","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001214659-24-018614","line_url":"/filing/0001214659-24-018614#line-1","is_derivative":false,"issuer_cik":"0001581280","issuer_name":"Twist Bioscience Corp","issuer_ticker":"TWST","issuer_name_source":null,"issuer_url":"/issuer/0001581280","owner_cik":"0001827198","owner_name":"Laponis Adam","owner_display_name":"Laponis Adam","owner_url":"/insider/0001827198","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4160.0,"shares_display":"4,160","price_per_share":44.605,"price_display":"44.60","price_state":"stated","total_value":185556.8,"total_display":"185,556.80","total_whole":"185,557","shares_owned_after":89237.0,"shares_owned_after_display":"89,237","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-06","filed_date":"2024-11-08","scope":"insider"},{"id":3133048,"accession":"0001214659-24-017482","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001214659-24-017482","line_url":"/filing/0001214659-24-017482#line-1","is_derivative":false,"issuer_cik":"0001581280","issuer_name":"Twist Bioscience Corp","issuer_ticker":"TWST","issuer_name_source":null,"issuer_url":"/issuer/0001581280","owner_cik":"0001827198","owner_name":"Laponis Adam","owner_display_name":"Laponis Adam","owner_url":"/insider/0001827198","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":856.0,"shares_display":"856","price_per_share":41.812,"price_display":"41.81","price_state":"stated","total_value":35791.072,"total_display":"35,791.07","total_whole":"35,791","shares_owned_after":73397.0,"shares_owned_after_display":"73,397","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-10-09","filed_date":"2024-10-11","scope":"insider"},{"id":2993549,"accession":"0001214659-24-012259","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001214659-24-012259","line_url":"/filing/0001214659-24-012259#line-1","is_derivative":false,"issuer_cik":"0001581280","issuer_name":"Twist Bioscience Corp","issuer_ticker":"TWST","issuer_name_source":null,"issuer_url":"/issuer/0001581280","owner_cik":"0001827198","owner_name":"Laponis Adam","owner_display_name":"Laponis Adam","owner_url":"/insider/0001827198","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":842.0,"shares_display":"842","price_per_share":48.913,"price_display":"48.91","price_state":"stated","total_value":41184.746,"total_display":"41,184.75","total_whole":"41,185","shares_owned_after":73602.0,"shares_owned_after_display":"73,602","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-07-09","filed_date":"2024-07-11","scope":"insider"},{"id":2270276,"accession":"0001214659-24-006630","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001214659-24-006630","line_url":"/filing/0001214659-24-006630#line-1","is_derivative":false,"issuer_cik":"0001581280","issuer_name":"Twist Bioscience Corp","issuer_ticker":"TWST","issuer_name_source":null,"issuer_url":"/issuer/0001581280","owner_cik":"0001827198","owner_name":"Laponis Adam","owner_display_name":"Laponis Adam","owner_url":"/insider/0001827198","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":556.0,"shares_display":"556","price_per_share":33.155,"price_display":"33.16","price_state":"stated","total_value":18434.18,"total_display":"18,434.18","total_whole":"18,434","shares_owned_after":74444.0,"shares_owned_after_display":"74,444","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-04-09","filed_date":"2024-04-11","scope":"insider"},{"id":8630087,"accession":"0001209191-23-046243","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-046243","line_url":"/filing/0001209191-23-046243#line-1","is_derivative":false,"issuer_cik":"0001719395","issuer_name":"Eargo, Inc.","issuer_ticker":"EAR","issuer_name_source":null,"issuer_url":"/issuer/0001719395","owner_cik":"0001827198","owner_name":"Laponis Adam","owner_display_name":"Laponis Adam","owner_url":"/insider/0001827198","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19.0,"shares_display":"19","price_per_share":3.2353,"price_display":"3.24","price_state":"stated","total_value":61.4707,"total_display":"61.47","total_whole":"61","shares_owned_after":3152.0,"shares_owned_after_display":"3,152","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-17","filed_date":"2023-08-17","scope":"insider"},{"id":8499917,"accession":"0001209191-23-030591","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-030591","line_url":"/filing/0001209191-23-030591#line-1","is_derivative":false,"issuer_cik":"0001719395","issuer_name":"Eargo, Inc.","issuer_ticker":"EAR","issuer_name_source":null,"issuer_url":"/issuer/0001719395","owner_cik":"0001827198","owner_name":"Laponis Adam","owner_display_name":"Laponis Adam","owner_url":"/insider/0001827198","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19.0,"shares_display":"19","price_per_share":4.6901,"price_display":"4.69","price_state":"stated","total_value":89.1119,"total_display":"89.11","total_whole":"89","shares_owned_after":3171.0,"shares_owned_after_display":"3,171","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-17","filed_date":"2023-05-18","scope":"insider"},{"id":7949375,"accession":"0001209191-23-011623","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-011623","line_url":"/filing/0001209191-23-011623#line-1","is_derivative":false,"issuer_cik":"0001719395","issuer_name":"Eargo, Inc.","issuer_ticker":"EAR","issuer_name_source":null,"issuer_url":"/issuer/0001719395","owner_cik":"0001827198","owner_name":"Laponis Adam","owner_display_name":"Laponis Adam","owner_url":"/insider/0001827198","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":21.0,"shares_display":"21","price_per_share":7.3701,"price_display":"7.37","price_state":"stated","total_value":154.7721,"total_display":"154.77","total_whole":"155","shares_owned_after":3190.0,"shares_owned_after_display":"3,190","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-17","filed_date":"2023-02-22","scope":"insider"},{"id":6201232,"accession":"0000899243-22-036555","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-036555","line_url":"/filing/0000899243-22-036555#line-1","is_derivative":false,"issuer_cik":"0001719395","issuer_name":"Eargo, Inc.","issuer_ticker":"EAR","issuer_name_source":null,"issuer_url":"/issuer/0001719395","owner_cik":"0001827198","owner_name":"Laponis Adam","owner_display_name":"Laponis Adam","owner_url":"/insider/0001827198","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":687.0,"shares_display":"687","price_per_share":0.5192,"price_display":"0.52","price_state":"stated","total_value":356.6904,"total_display":"356.69","total_whole":"357","shares_owned_after":59227.0,"shares_owned_after_display":"59,227","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-17","filed_date":"2022-11-21","scope":"insider"},{"id":4868192,"accession":"0000899243-21-026983","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-21-026983","line_url":"/filing/0000899243-21-026983#line-2","is_derivative":false,"issuer_cik":"0001719395","issuer_name":"Eargo, Inc.","issuer_ticker":"EAR","issuer_name_source":null,"issuer_url":"/issuer/0001719395","owner_cik":"0001827198","owner_name":"Laponis Adam","owner_display_name":"Laponis Adam","owner_url":"/insider/0001827198","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":38.43,"price_display":"38.43","price_state":"stated","total_value":384300.0,"total_display":"384,300.00","total_whole":"384,300","shares_owned_after":60568.0,"shares_owned_after_display":"60,568","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-29","filed_date":"2021-07-01","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":32,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":32,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":32},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001581280","name":"Twist Bioscience Corp","url":"/issuer/0001581280","role":"Officer (Chief Financial Officer)","n_filings":26,"first_seen":"2024-04-11","last_seen":"2026-08-25"},{"type":"issuer","type_label":"ISSUER","cik":"0001719395","name":"Eargo, Inc.","url":"/issuer/0001719395","role":"Officer (Chief Financial Officer)","n_filings":5,"first_seen":"2021-07-01","last_seen":"2023-08-17"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001827198","retrieved_at":"2026-08-26T07:01:25+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}